Ventria Bioscience Competitors and Similar CompaniesClear all
Travere Therapeutics's competitors and similar companies include Sosei Heptares and Heron Therapeutics.
 Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. | ||
Founding Date | Founding Date 2011 | Founding Date 1990 | Founding Date 1983 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ Dublin, IE | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB | Locations San Diego, US HQ |
Employees | Employees 46293% increase | Employees 387 | Employees 20333% decrease |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) 697 m | Valuation ($) 268.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) ¥29.6b (FY, 2025) | Revenue (est.) $154.9m (FY, 2025) |
Cost of goods | Cost of goods $10.3m (FY, 2025) | Cost of goods ¥7.3b (FY, 2025) | Cost of goods $41.3m (FY, 2025) |
Gross profit | Gross profit $480.4m (FY, 2025) | Gross profit ¥24b (FY, 2025) | Gross profit $113.6m (FY, 2025) |
Net income | Net income ($25.5m) (FY, 2025) | Net income (¥12.5b) (FY, 2025) | Net income ($20.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 25m | Total funding raised $ 65m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Sosei Heptares
HQ
Tokyo, JP
Employees
387
Sosei Heptares is a biopharmaceutical company that specializes in drug development.
View companyHeron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View company